Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $435-Report Released on 23 January 2024
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter has reaffirmed a Buy rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $390 to $435.
January 24, 2024 | 2:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities analyst Richard Newitter maintains a Buy rating on Intuitive Surgical and raises the price target to $435.
The increase in price target by Truist Securities reflects a positive outlook on Intuitive Surgical's stock, suggesting potential upside. This could lead to increased investor confidence and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100